Your browser is no longer supported. Please, upgrade your browser.
Settings
LH [NYSE]
Laboratory Corporation of America Holdings
IndexS&P 500 P/E10.31 EPS (ttm)28.17 Insider Own0.10% Shs Outstand96.30M Perf Week0.35%
Market Cap28.19B Forward P/E17.16 EPS next Y16.92 Insider Trans-8.48% Shs Float95.11M Perf Month0.98%
Income2.76B PEG- EPS next Q4.13 Inst Own92.10% Short Float1.69% Perf Quarter-5.33%
Sales16.55B P/S1.70 EPS this Y90.00% Inst Trans-1.46% Short Ratio2.72 Perf Half Y9.94%
Book/sh109.29 P/B2.66 EPS next Y-37.91% ROA13.50% Target Price336.14 Perf Year47.64%
Cash/sh20.97 P/C13.84 EPS next 5Y-9.00% ROE27.50% 52W Range195.88 - 309.60 Perf YTD42.63%
Dividend- P/FCF10.15 EPS past 5Y29.60% ROI12.10% 52W High-6.23% Beta1.01
Dividend %- Quick Ratio1.90 Sales past 5Y10.00% Gross Margin37.20% 52W Low48.21% ATR7.32
Employees72400 Current Ratio2.10 Sales Q/Q4.30% Oper. Margin23.10% RSI (14)54.43 Volatility2.61% 2.53%
OptionableYes Debt/Eq0.52 EPS Q/Q-15.60% Profit Margin16.70% Rel Volume0.81 Prev Close291.27
ShortableYes LT Debt/Eq0.52 EarningsOct 28 BMO Payout0.00% Avg Volume592.32K Price290.32
Recom1.70 SMA201.60% SMA502.56% SMA2005.69% Volume480,009 Change-0.33%
Jan-11-21Upgrade Argus Hold → Buy $245
Jan-11-21Downgrade Wolfe Research Peer Perform → Underperform
Jan-08-21Downgrade Wolfe Research Outperform → Peer Perform
Jul-14-20Upgrade BofA Securities Neutral → Buy $194 → $220
Jul-13-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Resumed Deutsche Bank Buy $210
May-15-20Upgrade Mizuho Neutral → Buy $158 → $186
Apr-29-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $204 → $214
Jan-08-20Initiated Wells Fargo Overweight $210
Jul-16-19Upgrade BofA/Merrill Underperform → Neutral
Jun-21-19Upgrade Deutsche Bank Hold → Buy $180 → $220
Apr-02-19Upgrade Jefferies Hold → Buy $154 → $190
Jan-17-19Initiated UBS Buy $169
Jan-03-19Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18Downgrade Craig Hallum Buy → Hold
Oct-30-18Downgrade Argus Buy → Hold
Oct-25-18Downgrade Canaccord Genuity Buy → Hold $190 → $162
Oct-19-18Resumed BofA/Merrill Buy
Dec-03-21 12:34PM  
11:31AM  
10:11AM  
08:25AM  
06:49AM  
Dec-02-21 08:12AM  
Dec-01-21 02:22PM  
09:36AM  
07:31AM  
07:21AM  
Nov-30-21 07:22AM  
07:03AM  
Nov-29-21 10:20AM  
08:22AM  
Nov-26-21 08:17AM  
Nov-25-21 08:59AM  
07:16AM  
12:49AM  
Nov-24-21 10:36AM  
09:53AM  
09:00AM  
Nov-23-21 10:59AM  
10:58AM  
07:54AM  
07:54AM  
Nov-22-21 04:07PM  
11:40AM  
10:16AM  
Nov-20-21 08:31AM  
Nov-19-21 09:48AM  
09:35AM  
08:13AM  
Nov-18-21 09:11AM  
07:33AM  
07:09AM  
Nov-17-21 10:13AM  
09:26AM  
09:25AM  
05:56AM  
Nov-16-21 08:06AM  
07:57AM  
07:57AM  
Nov-15-21 08:53AM  
08:52AM  
08:44AM  
03:00AM  
Nov-12-21 10:49AM  
09:27AM  
08:33AM  
08:33AM  
Nov-11-21 10:46AM  
Nov-10-21 09:50AM  
Nov-09-21 09:53AM  
07:32AM  
Nov-08-21 02:41PM  
09:30AM  
07:03AM  
Nov-05-21 11:50AM  
11:40AM  
Nov-04-21 05:57PM  
Nov-02-21 04:36PM  
12:20PM  
09:00AM  
Nov-01-21 10:01AM  
Oct-29-21 02:18PM  
Oct-28-21 05:00PM  
10:52AM  
09:53AM  
09:15AM  
06:59AM  
Oct-27-21 08:32AM  
Oct-22-21 11:03AM  
10:54AM  
10:32AM  
Oct-21-21 03:02PM  
11:08AM  
Oct-20-21 11:50AM  
11:40AM  
Oct-19-21 12:10PM  
Oct-15-21 09:10AM  
Oct-14-21 10:00AM  
Oct-13-21 07:14AM  
Oct-08-21 07:43AM  
Oct-06-21 11:50AM  
Oct-04-21 12:11PM  
10:42AM  
Oct-01-21 11:49AM  
10:12AM  
Sep-28-21 04:18PM  
09:36AM  
Sep-27-21 08:30AM  
Sep-14-21 10:26AM  
09:58AM  
Sep-13-21 04:35PM  
Sep-10-21 09:28AM  
Sep-08-21 04:12PM  
Sep-02-21 06:38PM  
05:18PM  
04:33PM  
Aug-30-21 11:57AM  
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
van der Vaart Sandra DEVP, Chief Legal OfficerSep 15Option Exercise84.864,500381,8709,765Sep 17 12:20 PM
van der Vaart Sandra DEVP, Chief Legal OfficerSep 15Sale296.784,5001,335,5105,265Sep 17 12:20 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 07Option Exercise84.864,500381,8709,737Jun 09 02:03 PM
van der Vaart Sandra DEVP, Chief Legal OfficerJun 07Sale266.564,5001,199,5205,237Jun 09 02:03 PM
Kirchgraber Paul RCEO, Covance Drug DevelopmentMay 06Sale276.552,500691,3757,844May 10 08:21 AM
BELINGARD JEAN-LUCDirectorMay 03Option Exercise98.492,600256,07418,169May 05 10:48 AM
BELINGARD JEAN-LUCDirectorMay 03Sale269.162,600699,80315,569May 05 10:48 AM
van der Vaart Sandra DEVP, Chief Legal OfficerMar 30Sale251.88812204,5275,237Apr 01 08:32 AM
Schroeder Mark SEVP, President-Diagnostics LabMar 30Sale251.88667168,0045,006Apr 01 08:32 AM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 18Option Exercise157.092,166340,2512,660Feb 19 02:17 PM
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 18Sale241.512,317559,589343Feb 19 02:17 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 16Sale236.5520849,2024,426Feb 17 04:28 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 16Sale237.0618844,5674,339Feb 17 04:27 PM
van der Vaart Sandra DEVP, Chief Legal OfficerFeb 05Sale225.8510924,6184,219Feb 08 03:43 PM
Schroeder Mark SEVP, President-Diagnostics LabFeb 05Sale225.8520345,8484,152Feb 08 03:40 PM
Williams R SandersDirectorJan 26Option Exercise98.491,300128,0375,246Jan 28 12:11 PM